Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $46.6800 (-0.7%) ($46.3450 - $47.1500) on Fri. Feb. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.23% (three month average) | RSI | 62 | Latest Price | $46.6800(-0.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.3% a day on average for past five trading days. | Weekly Trend | BAX advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(36%) IWD(35%) SPLV(35%) SDY(34%) ARKG(32%) | Factors Impacting BAX price | BAX will decline at least -1.115% in a week (0% probabilities). VIXM(-22%) VXX(-11%) MCHI(-11%) GLD(-10%) FXI(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.115% (StdDev 2.23%) | Hourly BBV | 0.4 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $46.16(1.13%) | 10 Day Moving Average | $45.94(1.61%) | 20 Day Moving Average | $45.5(2.59%) | To recent high | -17.4% | To recent low | 7% | Market Cap | $23.815b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |